MB
MPM BioImpact’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Sell |
313,571
-2,478
| -0.8% | -$117K | 2.56% | 13 |
|
|
2025
Q1 | $12.3M | Buy |
316,049
+819
| +0.3% | +$32K | 2.12% | 17 |
|
|
2024
Q4 | $17.1M | Sell |
315,230
-33,833
| -10% | -$1.83M | 2.42% | 15 |
|
|
2024
Q3 | $17.6M | Buy |
349,063
+5,828
| +2% | +$294K | 2.64% | 13 |
|
|
2024
Q2 | $15.1M | Buy |
343,235
+47,185
| +16% | +$2.07M | 2.35% | 11 |
|
|
2024
Q1 | $14.9M | Buy |
296,050
+1,474
| +0.5% | +$74K | 2.39% | 12 |
|
|
2023
Q4 | $17.8M | Buy |
294,576
+386
| +0.1% | +$23.3K | 4.16% | 7 |
|
|
2023
Q3 | $16.8M | Sell |
294,190
-921
| -0.3% | -$52.5K | 4.48% | 7 |
|
|
2023
Q2 | $15.1M | Buy |
+295,111
| New | +$15.1M | 3.03% | 12 |
|